Source: Pixabay.com

Second Ever Cancer Treatment Based on Biomarkers Approved by FDA

Post author:Trudy Horsting
Post published:November 29, 2018
Post category:Rare Disease Salivary gland cancer- adult Soft Tissue Sarcoma Thyroid Cancer

On November 26, 2018, a new drug was given accelerated approval by the FDA. Not only that, but it was granted orphan drug designation and breakthrough therapy designation. The drug…

Share Your Story

February is RARE DISEASE MONTH! Patient Worthy believes that every rare story deserves to be told. Click below to tell us yours.

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Share Your Story

Second Ever Cancer Treatment Based on Biomarkers Approved by FDA

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Share Your Story

Let’s Work Together!

Keep Up to Date

Learn More